Significant variation in mortality and functional outcome after acute ischaemic stroke between western countries: Data from the tinzaparin in acute ischaemic stroke trial (TAIST)

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 77, Issue 3, 2006, Pages 327-333

  Gray, L J ^a   Sprigg, N ^a   Bath, Philip M W ^a   Sorensen P ^b   Lindenstrom E ^b   Boysen, G ^c   De Deyn, P P ^d   Friis, P ^e   Leys, D ^f   Marttila, R ^g   Olsson, J E ^h   O'Neill, D ⁱ   Ringelstein, B ^j   Van Der Sande, J J ^k   Turpie, A G G ^l  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LEO PHARMA A S   (Denmark)

^c BISPEBJERG HOSPITAL   (Denmark)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e Anestesiavdelingen Vest Agder sentralsykehus   (Norway)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g TURKU UNIVERSITY HOSPITAL   (Finland)

^h LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

ⁱ ADELAIDE AND MEATH HOSPITAL   (Ireland)

^j UNIVERSITY OF MÜNSTER   (Germany)

^k SLOTERVAART HOSPITAL   (Netherlands)

^l HAMILTON GENERAL HOSPITAL   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

TINZAPARIN;

ADULT; ARTICLE; CANADA; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; DEMOGRAPHY; FATALITY; FEMALE; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NORTH AMERICA; PATIENT CARE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK FACTOR; SCANDINAVIA; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; CEREBRAL INFARCTION; CROSS-CULTURAL COMPARISON; DIAGNOSIS-RELATED GROUPS; DOSE-RESPONSE RELATIONSHIP, DRUG; EUROPE; FEMALE; FIBRINOLYTIC AGENTS; GREAT BRITAIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; MIDDLE AGED; NORTH AMERICA; PROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 33644526948     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2005.064600     Document Type: Article

References (29)

1. Aho K, Harmsen S, Marrquardsen J. Cerebrovascular disease in the community: results of a WHO collaborative study. Bull WH0 1980;58:11-30.
2. Thorvaldsen P, Asplund K, Kuulasmaa K, et al. Stroke incidence, case fatality and mortality in the WHO MONICA project. World Health Organisation Monitoring Trends and Determinants in Cardiovascular Disease. Stroke 1995;26:361-7.
3. Feigin VL, Lawes CM, Bennett DA, et al. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-natality in the late 20th century. Lancet Neural 2003;2:43-53.
4. Di Carlo A, Lamassa M, Baldereschi M, et al. Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003;34:1114-19.
5. Lamassa M, Di Carlo A, Pracucci G, et al. Characteristics, outcome, and care of stroke associated with atrial fibrillation in Europe: data from a multicenter multinational hospital-based registry (The European Community Stroke Project). Stroke 2001;32:392-8.
6. Di Carlo A, Lamassa M, Pracucci G, et al. Stroke in the very old: clinical presentation and determinants of 3-month functional outcome: a European perspective. Stroke 1999;30:2313-19.
7. Stroke Unit Trialists' Collaboration. Organised inpatient (stroke unit) care for stroke (Cochrane Review). Cochrane Library, issue 3. Oxford: Update Software (John Wiley and Sons), 2004.
8. Wolfe CD, Tilling K, Beech R, et al. Variations in case fatality and dependency from stroke in western and central Europe. The European BIOMED Study of Stroke Care Group. Stroke 1999;30:350-6.
9. Brainin M, Bornstein N, Boysen G, et al. Acute neurological stroke care in Europe: results of the European Stroke Care Inventory. Eur J Neurol 2000;7:5-10.
10. Weir NU, Sandercock PA, Lewis SC, et al. Variations between countries in outcome after stroke in the International Stroke Trial (IST). Stroke 2001;32:1370-7.
11. Asplund K, Ashburner S, Cargill K, et al. Health care resource use and stroke outcome. Int J Technol Assess Health Care 2003;19:267-77.
12. Bath P, Lindenstrom E, Boysen G, et al. Tinzaparin in acute ischaemic stroke (TAIST): a randomised aspirin-controlled trial. Lancet 2001;358:702-10.
13. Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003;16(suppl 1):14-19.
14. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke (Cochrane Review). Cochrane Library. Oxford: Update Software (John Wiley and Sons), 2002.
15. Davenport RJ, Dennis MS, Warlow CP. Effect of correcting outcome data for case mix: an example from stroke medicine. BMJ 1996;312:1503-5.
16. Orchard C. Comparing healthcare outcomes. BMJ 1994;308:1493-6.
17. Halm EA, Chassin MR. Why do hospital death rates vary? N Engl J Med 2001;345:692-4.
18. Collaboration SUTs. Organised inpatient (stroke unit) care after stoke (Cochrane Review). Cochrane Library. Oxford: Update Software (John Wiley and Sons), 2003.
19. Asplund K, Hulter-Ashberg K, Norrving B, et al. Riks-Stroke - a Swedish national quality register for stroke care. Cerebrovasc Dis 2003;15(suppl 1):5-7.
20. Chamie M. Survey design strategies for the study of disability. World Health Stat Q 1989;42:122-40.
21. Suris JC, Blum RW. Disability rates among adolescents: an international comparison. J Adolesc Health 1993;14:548-52.
22. Groce NE. Disability in cross-cultural perspective: rethinking disability. Lancet 1999;354:756-7.
23. McKevitt C, Beech R, Pound P, et al. Putting stroke outcomes into context: assessment of variations in the processes or care. Eur J Public Health 2000;10:120-6.
24. Lees K, Lavelle JF, Cunha L, et al. Glycine antagonist (GV 150526) in acute stroke: a multicentre, double-blind placebo controlled phase II trial. Cerebrovasc Dis 2001;11:20-9.
25. Langhorne P, Tong B, Stott DJ. Association between physiological homeostasis and early recovery after stroke. Stroke 2000;31:2526-7.
26. Sulter G, Elting JW, Langedijk M, et al. Admitting acute ischaemic stroke patients to a stroke care monitoring unit versus a conventional stroke unit: a randomised pilot study. Stroke 2003;34:101-4.
27. Wardlaw JM, del Zoppo G, Yamaguchi T. Thrombolysis for acute ischaemic stroke (Cochrane Review). Cochrane Library. Oxford: Update Software (John Wiley and Sons), 2001.
28. Langhorne P, Dennis M. Stroke units: the next 10 years. Lancet 2004;363:834-5.
29. Bath P, Soerensen P, Lindenstrom E. Outcome after stroke varies between countries: data from the "Tinzaparin in Acute Ischaemic Stroke Trial" (TAIST) [abstract]. Cerebrovasc Dis 2001;11(suppl 47).